 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
|
|
|
|
Phase III, Phase II
|
|
|
|
RPCI-RP-9815
NCI-V99-1527, NCT00003816, RP 98-15
|
|
| |
Stem Cell Transplantation for Hematological Malignancies
|
|
|
|
Phase III, Phase II
|
|
|
|
0005M52481
MT2000-12, NCT00176839
|
|
| |
Stem Cell Transplant for Bone Marrow Failures
|
|
|
|
Phase III, Phase II
|
|
|
|
9504M09637
MT2000-18, NCT00176878
|
|
| |
Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
|
|
|
|
Phase III, Phase II
|
|
|
|
GC P#02.01.001
NCT00469729
|
|
| |
In-Vivo Activated T-Cell Depletion to Prevent GVHD
|
|
|
|
Phase III, Phase II
|
|
|
|
0705-20 IUCRO-0196
NCT00594308
|
|
| |
Chemotherapy With or Without Total-Body Irradiation in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Myelodysplastic Syndromes or Acute Myeloid Leukemia
|
|
|
|
Phase III
|
|
|
|
FHCRC-1992.00
6170, NCT00322101, NHLBI-K23-HL084054-01A1
|
|
| |
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
|
|
|
|
Phase III
|
|
|
|
COG-AAML0431
AAML0431, NCT00369317
|
|
| |
Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases
|
|
|
|
Phase III
|
|
|
|
CBMTG-0601
NCT00438958
|
|
| |
Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers
|
|
|
|
Phase III
|
|
|
|
418
BMTCTN-0201, NCT00075816
|
|
| |
Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia
|
|
|
|
Phase III
|
|
|
|
467
BMT CTN 0501, 5 U01 HL69294-05, NCT00412360
|
|
